产品名称 | NebuSelect™ Recombinant Human CD200/OX-2, hFc-tag |
---|---|
目录号 | NBL-242944 |
别名 | CD200/OX-2; CD200; MOX1; MOX2; My033; MRC; OX-2; OX2 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P41217-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242944-100ug | 100ug | Inquire | Inquire | |
NBL-242944-1mg | 1mg | Inquire | Inquire | |
NBL-242944-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human CD200/OX-2, hFc-tag
Catalog#:
NBL-242944
Description:
NebuSelect™ Recombinant Human CD200/OX-2, hFc-tag(Cat#NBL-242944) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Gln31-Gly232.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 49.2 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
CD200/OX-2; CD200; MOX1; MOX2; My033; MRC; OX-2; OX2
Target Information:
CD200 and its receptors are highly expressed in the lung, on epithelial cells and leukocytes, and emerging evidence links dysregulation of the CD200 pathway with asthma. Moreover, pharmacological modulation of CD200 receptors was shown to improve clinical and inflammatory outcomes of preclinical asthma models.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.